But Lucentis has to be injected into the eye every month or two, a burden for patients and doctors.
使用Lucentis治疗需要每一两个月进行眼部注射,无论对患者还是医生来说,都是一个沉重负担。
But an unusual conflict of interest means that Genentech, the drug company that produces Lucentis, is conspicuously silent.
但是一个不同寻常的利益冲突意味着制药公司基因泰克对此格外地沉默。
Medicare could save hundreds of millions of dollars a year if everyone used the cheaper drug, Avastin, instead of the costlier one, Lucentis.
如果每个人都使用更便宜的药物安维汀,而不是更昂贵的雷珠单抗,那么医疗保障每年就可以节省数亿美元。
应用推荐